Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
residual concentration | drug still measurable after a defined elapsed interval | A residual concentration was measured the day after the last recorded dose. | Objective | Drug levels - collection and dose timing |
sensor active time | proportion of a monitoring interval with available sensor data | Sensor active time was reported alongside the glucose summary. | Objective | Glucose monitoring, endocrine testing and urine studies |
spot specimen | single collection without accumulation over a prolonged timed interval | Request a spot specimen as specified on the laboratory order. | Plan | Specimen collection, imaging and follow-up procedures |
stable | little meaningful change during the stated interval | Exertional symptoms have been stable for three months. | Assessment | Course, severity and prognosis |
steady state | repeated dosing produces a reproducible concentration pattern each interval | Whether steady state was reached is uncertain after the recent regimen change. | Assessment | Drug levels - exposure and pharmacokinetics |
temporary hold instruction | instructions to omit treatment for a defined condition or interval | Write the temporary hold instruction with the trigger and responsible prescriber. | Plan | Medication reconciliation, administration and teaching |
therapeutic range | concentration interval used as a treatment reference for a specified context | The applicable therapeutic range depends on the drug, specimen, timing and indication. | Assessment | Drug levels - exposure and pharmacokinetics |
timed urine volume | total amount of urine collected over a specified interval | Timed urine volume was recorded with start and finish times. | Objective | Glucose monitoring, endocrine testing and urine studies |
time to next dose | interval from collection until the following administration | The time to next dose was 12 minutes on the signed record. | Objective | Drug levels - collection and dose timing |
transient abnormality | finding was present for a limited interval and then resolved | The transient abnormality was documented with the times of the initial and repeat examinations. | Assessment | Precision in clinical interpretation and documentation |
turnaround time | expected interval before a test or service is completed | Confirm the expected turnaround time before scheduling result review. | Plan | Specimen collection, imaging and follow-up procedures |
unchanged regimen | dose and schedule remained the same over the stated interval | Confirm an unchanged regimen and review missed doses before classifying steady state. | Plan | Drug levels - verification and documentation |
upper limit | highest applicable value on a stated scale or interval | The assay upper limit is given in the laboratory comment. | Objective | Drug levels - analyte, specimen and reporting |
accumulation ratio | measure of exposure after repeated dosing relative to a stated earlier exposure | The reported accumulation ratio compares the same exposure metric across intervals. | Assessment | Drug concentrations, exposure and assay interpretation |
alkaline phosphatase | enzyme measured in hepatobiliary and bone assessment | The repeat alkaline phosphatase remains above the laboratory interval. | Objective | Hepatobiliary, pancreatic and nutrition findings |
| minimum concentration in the specified concentration-time profile | The modeled Cmin corresponds to the end of the stated interval. | Assessment | Drug levels - exposure and pharmacokinetics | |
colicky | pain comes in waves | Reports colicky abdominal pain with pain-free intervals. | Subjective | Character and triggers |
conditional prognosis | expected course depends on a specified event, response or finding | Conditional prognosis was explained in terms of functional recovery over the next assessment interval. | Assessment | Precision in clinical interpretation and documentation |
dose-normalized AUC | area under the concentration-time curve divided by the administered dose | The team compared dose-normalized AUC using the same AUC interval in both periods. | Assessment | Drug concentrations, exposure and assay interpretation |
dose timing diary | record of actual dose times used to interpret exposure or symptoms | Request a dose timing diary for the interval surrounding the next sample. | Plan | Documentation, follow-up and transitions |
fetal heart rate baseline | average fetal heart rate determined over an appropriate tracing segment | Fetal heart rate baseline was recorded with the tracing interval. | Objective | Obstetric and postpartum documentation |
fistula output monitoring | tracking fluid volume from an abnormal tract | Record the collection interval during fistula output monitoring. | Plan | Procedure, specimen and wound plans |
flucytosine | antifungal monitored using drug- and protocol-specific sampling | The flucytosine sample is documented with its exact postdose interval. | Objective | Drug levels - named analytes and exposure reports |
free protein S antigen | quantity of the unbound form of protein S | The free protein S antigen was reported with the applicable reference interval. | Objective | Coagulation, antibodies and hemostasis studies |
free thyroxine | unbound fraction of the thyroid hormone T4 | Free thyroxine was reported with the method-specific reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |